Ultrasound-targeted microbubble destruction mediated miR-492 inhibitor suppresses the tumorigenesis in non-small cell lung cancer

References

• Chen R, Tao Y, Xu X, et al. The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer. Discov Med. 2018;26(143):155–166.
   PubMed Web of Science ®Google Scholar
• Tan AC. Targeting the PI3K/akt/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11(3):511–518.
   PubMed Web of Science ®Google Scholar
• Gelatti ACZ, Drilon A, Santini FC. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Lung Cancer. 2019;137:113–122.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Nagasaka M, Gadgeel SM. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer. Expert Rev Anticancer Ther. 2018;18(1):63–70.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Yang F, Lin Y, et al. New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery. Curr Gene Ther. 2013;13(4):250–274.
   PubMed Web of Science ®Google Scholar
• Bastarrachea RA, Chen J, Kent JW, Jr, et al. Engineering brown fat into skeletal muscle using ultrasound-targeted microbubble destruction gene delivery in obese Zucker rats: proof of concept design. IUBMB Life. 2017;69(9):745–755.
   PubMed Web of Science ®Google Scholar
• Vu V, Liu Y, Sen S, et al. Delivery of adiponectin gene to skeletal muscle using ultrasound targeted microbubbles improves insulin sensitivity and whole body glucose homeostasis. Am J Physiol Endocrinol Metab. 2013;304(2):E168–E175.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu B, Huang J, et al. Ultrasound-targeted microbubble destruction augmented synergistic therapy of rheumatoid arthritis via targeted liposomes. J Mater Chem B. 2020;8(24):5245–5256.
   PubMed Web of Science ®Google Scholar
• Li X, Xu M, Lv W, et al. Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer. Exp Ther Med. 2020;19(5):3391–3397.
   PubMed Web of Science ®Google Scholar
• Wu H, Xie D, Yang Y, et al. Ultrasound-targeted microbubble destruction-mediated miR-206 overexpression promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells via targeting PPIB. Technol Cancer Res Treat. 2020;19:1533033820959355.
   Web of Science ®Google Scholar
• Lee SS, Cheah YK. The interplay between microRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.
   PubMed Web of Science ®Google Scholar
• Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):424–432.
   PubMed Web of Science ®Google Scholar
• von Frowein J, Pagel P, Kappler R, et al. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology. 2011;53(3):833–842.
   PubMed Web of Science ®Google Scholar
• Guo LL, Chen HH, Qu FC, et al. Clinical significance of miR-492 in peripheral blood of acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2020;24(17):9041–9045.
   PubMed Web of Science ®Google Scholar
• Wang K, Lu H, Qu H, et al. miR-492 promotes cancer progression by targeting GJB4 and is a novel biomarker for bladder cancer. Onco Targets Ther. 2019;12:11453–11464.
   PubMed Web of Science ®Google Scholar
• Shi LP, Liang M, Li FF, et al. MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression. Eur Rev Med Pharmacol Sci. 2019;23(3):992–1001.
   PubMed Web of Science ®Google Scholar
• Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res. 2017;23(17):5311–5319.
   PubMed Web of Science ®Google Scholar
• Chen Y, Min L, Ren C, et al. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer. PLoS One. 2017;12(2):e0171751.
   PubMed Web of Science ®Google Scholar
• Pennell NA, Arcila ME, Gandara DR, et al. Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices. Am Soc Clin Oncol Educ Book. 2019;39:531–542.
   PubMedGoogle Scholar
• Wadowska K, Bil-Lula I, Trembecki L, et al. Genetic markers in lung cancer diagnosis: a review. Int J Mol Sci. 2020;21(13):4569.
   PubMed Web of Science ®Google Scholar
• Didkowska J, Wojciechowska U, Mańczuk M, et al. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4(8):150.
   PubMed Web of Science ®Google Scholar
• Rahal Z, El Nemr S, Sinjab A, et al. Smoking and lung cancer: a geo-regional perspective. Front Oncol. 2017;7:194.
   PubMed Web of Science ®Google Scholar
• Soria JC, Massard C, Le Chevalier T. Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? Ann Oncol. 2010;21(12):2324–2332.
   PubMed Web of Science ®Google Scholar
• Pidikova P, Reis R, Herichova I. miRNA clusters with down-regulated expression in human colorectal cancer and their regulation. Int J Mol Sci. 2020;21(13):4633.
   PubMed Web of Science ®Google Scholar
• Wang C, Huang Y, Zhang J, et al. MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1. Exp Mol Pathol. 2020;115:104449.
   PubMed Web of Science ®Google Scholar
• Kondrotiene A, Dauksa A, Pamedytyte D, et al. Plasma-derived miRNA-222 as a candidate marker for papillary thyroid cancer. Int J Mol Sci. 2020;21(17):6445.
   PubMed Web of Science ®Google Scholar
• Chang Y, Hao M, Jia R, et al. Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axis. Cancer Cell Int. 2021;21(1):29.
   PubMed Web of Science ®Google Scholar
• Garnham R, Scott E, Livermore KE, et al. ST6GAL1: a key player in cancer. Oncol Lett. 2019;18(2):983–989.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen L, Ren Z, et al. Influences of two significant variants located in the ST6GAL1 3'-untranslated region on lung carcinoma susceptibility in the Chinese Han population. Eur J Cancer Prev. 2020;29(1):60–64.
   PubMed Web of Science ®Google Scholar
• Kang HG, Yoo SS, Choi JE, et al. Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer. Oncotarget. 2017;8(37):61777–61785.
   PubMedGoogle Scholar
• Bosch PJ, Peek SL, Smolikove S, et al. Akirin proteins in development and disease: critical roles and mechanisms of action. Cell Mol Life Sci. 2020;77(21):4237–4254.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Liu L, et al. Tissue targeting and ultrasound-targeted microbubble destruction delivery of plasmid DNA and transfection in vitro. Cell Mol Bioeng. 2020;13(1):99–112.
   PubMed Web of Science ®Google Scholar
• Deng Q, Hu B, Cao S, et al. Improving the efficacy of therapeutic angiogenesis by UTMD-mediated ang-1 gene delivery to the infarcted myocardium. Int J Mol Med. 2015;36(2):335–344.
   PubMed Web of Science ®Google Scholar
• Sun W, Li Z, Zhou X, et al. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction. Drug Deliv. 2019;26(1):45–50.
   PubMed Web of Science ®Google Scholar
• Lin L, Fan Y, Gao F, et al. UTMD-promoted co-delivery of gemcitabine and miR-21 inhibitor by dendrimer-entrapped gold nanoparticles for pancreatic cancer therapy. Theranostics. 2018;8(7):1923–1939.
   PubMed Web of Science ®Google Scholar
• Qin D, Li H, Xie H. Ultrasoundtargeted microbubble destructionmediated miR205 enhances cisplatin cytotoxicity in prostate cancer cells. Mol Med Rep. 2018;18(3):3242–3250.
   PubMed Web of Science ®Google Scholar
• Takase Y, Takahashi Y. Blood flow-mediated gene transfer and siRNA-knockdown in the developing vasculature in a spatio-temporally controlled manner in chicken embryos. Dev Biol. 2019;456(1):8–16.
   PubMed Web of Science ®Google Scholar
• Shi B, Xue M, Wang Y, et al. An improved method for increasing the efficiency of gene transfection and transduction. Int J Physiol Pathophysiol Pharmacol. 2018;10(2):95–104.
   PubMedGoogle Scholar
• Aung-Htut MT, McIntosh CS, West KA, et al. In vitro validation of phosphorodiamidate morpholino oligomers. Molecules. 2019;24(16):2922.
   PubMed Web of Science ®Google Scholar